DeepMed Research

Shionogi, Inc

🇯🇵Japan

Country: 🇯🇵Japan

Ownership: -

Established: 1919-01-01

Employees: -

Market Cap: $13.1B

Website: https://www.shionogi.com/jp/ja/

Clinical Trials

S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors

Phase 1

Recruiting

Conditions: Solid Tumors

Interventions: Drug: S-531011
Drug: pembrolizumab

First Posted Date: 2021-11-01

Last Posted Date: 2025-01-08

Lead Sponsor: Shionogi

Target Recruit Count: 274

Registration Number: NCT05101070

Locations: 🇺🇸
Henry Ford Health Center, Detroit, Michigan, United States
🇯🇵
National Cancer Center Hospital East, Kashiwa, Chiba, Japan
🇺🇸
Angeles Clinic and Research Center, Los Angeles, California, United States

and more 3 locations

Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler Device

Phase 1

Completed

Conditions: Healthy Volunteer

Interventions: Drug: Radio-labelled S-770108
Device: S-770108 Inhaler A1

First Posted Date: 2020-11-17

Last Posted Date: 2020-12-29

Lead Sponsor: Shionogi

Target Recruit Count: 12

Registration Number: NCT04631354

Locations: 🇬🇧
Simbec-Orion, Merthyr Tydfil, United Kingdom

Women's Satisfaction and Adherence to Vulvovaginal Atrophy Treatments

Completed

Conditions: Vulvovaginal Atrophy

First Posted Date: 2020-10-29

Last Posted Date: 2021-06-21

Lead Sponsor: Shionogi

Target Recruit Count: 831

Registration Number: NCT04607707

Locations: 🇪🇸
Clínica Teknon, Barcelona, Spain
🇪🇸
Hospital Universitario de Guadalajara, Guadalajara, Spain
🇪🇸
Instituto Palacios, Madrid, Spain

A Study of Naldemedine in Participants Undergoing Surgeries That Include a Bowel Resection or Bowel Transection

Phase 2

Terminated

Conditions: Postoperative Gastrointestinal Dysfunction

Interventions: Drug: Placebo
Drug: Naldemedine

First Posted Date: 2020-04-21

Last Posted Date: 2022-01-18

Lead Sponsor: Shionogi

Target Recruit Count: 2

Registration Number: NCT04355169

Locations: 🇺🇸
Norton Hospital, Louisville, Kentucky, United States
🇺🇸
Banner University Medical Center - Tucson, Tucson, Arizona, United States
🇺🇸
CHRISTUS Trinity Clinic Research, Tyler, Texas, United States

and more 5 locations

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants

Phase 2

Completed

Conditions: Hospital Acquired Pneumonia (HAP)
Complicated Urinary Tract Infection (cUTI)
Sepsis
Ventilator-acquired Pneumonia
Bloodstream Infections (BSI)
Complicated Intra-abdominal Infection (cIAI)
Gram-negative Bacterial Infections

Interventions: Drug: Cefiderocol
Drug: Standard of Care

First Posted Date: 2020-04-06

Last Posted Date: 2024-01-24

Lead Sponsor: Shionogi

Target Recruit Count: 54

Registration Number: NCT04335539

Locations: 🇱🇻
Bernu Kliniska Universitates Slimnica Childrens Hospital - Tornakalna, Riga, Latvia
🇪🇪
Tartu Ulikooli Kliinikum - Anestesioloogia ja Intensiivravi Kliinik, Tartu, Estonia
🇬🇪
JSC "Medical Corporation Evex" " M. Iashvili Batumi Maternal and Child Central Hospital", Batumi, Georgia

and more 20 locations

First-in-human Study of S-588210 (S-488210+S-488211)

Phase 1

Completed

Conditions: Lung Cancer
Mesothelioma
Head and Neck Cancer
Bladder Cancer
Esophageal Cancer

Interventions: Biological: S-488210
Biological: S-488211

First Posted Date: 2020-03-20

Last Posted Date: 2022-01-26

Lead Sponsor: Shionogi

Target Recruit Count: 10

Registration Number: NCT04316689

Locations: 🇬🇧
University College London Clinical Research Facility, London, United Kingdom

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants

Phase 2

Completed

Conditions: Hospital Acquired Bacterial Pneumonia (HABP)
Ventilator Associated Bacterial Pneumonia (VABP)
Gram-negative Bacterial Infections
Complicated Urinary Tract Infection (cUTI)

Interventions: Drug: Cefiderocol
Drug: Standard of Care

First Posted Date: 2020-01-02

Last Posted Date: 2024-11-18

Lead Sponsor: Shionogi

Target Recruit Count: 85

Registration Number: NCT04215991

Locations: 🇺🇸
University of Iowa Stead Family Children's Hospital, Iowa City, Iowa, United States
🇬🇪
JSC "EVEX Medical Corporation"- M Lashvili Childrens Central Hospital, Tbilisi, Georgia
🇬🇪
Ltd Unimedi Kakheti Childrens New Clinic, Tbilisi, Georgia

and more 22 locations

Evaluation of Safety, Tolerability, Pharmacokinetics, Drug-Drug and Food Interactions of Single and Multiple Doses of S-648414 in Healthy Adults

Phase 1

Completed

Conditions: Healthy Volunteer

Interventions: Drug: Placebo
Drug: S-648414
Drug: Midazolam
Drug: Dolutegravir

First Posted Date: 2019-11-01

Last Posted Date: 2021-11-01

Lead Sponsor: Shionogi

Target Recruit Count: 98

Registration Number: NCT04147715

Locations: 🇯🇵
P-One Clinic, Hachioji City, Toyko, Japan
🇺🇸
PPD Ph 1 Clinical Research Unit, Austin, Texas, United States

Evaluation of S-600918 in Adults With Refractory Chronic Cough

Phase 2

Completed

Conditions: Chronic Cough

Interventions: Drug: S-600918
Drug: Placebo to S-600918

First Posted Date: 2019-10-01

Last Posted Date: 2024-03-27

Lead Sponsor: Shionogi

Target Recruit Count: 406

Registration Number: NCT04110054

Locations: 🇺🇸
Research Solutions of Arizona, Litchfield Park, Arizona, United States
🇺🇸
Allergy & Asthma Associates of Southern California dba Southern California Research, Mission Viejo, California, United States
🇺🇸
Medical Research Of Central Florida, LLC, Leesburg, Florida, United States

and more 132 locations

Effect of Food and Calcium on Pharmacokinetics of a Single Dose of S-888711 in Healthy Adult Volunteers

Phase 1

Completed

Conditions: Healthy Volunteer

Interventions: Drug: S-888711
Dietary Supplement: Calcium Antacid

First Posted Date: 2019-04-01

Last Posted Date: 2019-04-01

Lead Sponsor: Shionogi

Target Recruit Count: 15

Registration Number: NCT03897413

Locations: 🇺🇸
Healthcare Discoveries, LLC, San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy